PI
PTLA

Putnam Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Putnam Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-28,456
Closed -$1.07M – 1182
2018
Q2 		$1.07M Buy
28,456
+2,309
+9% +$88.3K ﹤0.01% 839
2018
Q1 		$854K Hold
26,147
– – ﹤0.01% 883
2017
Q4 		$1.27M Buy
26,147
+20,647
+375% +$1.04M ﹤0.01% 853
2017
Q3 		$298K Buy
+5,500
New +$323K ﹤0.01% 1049
2017
Q2 		– Sell
-8,607
Closed -$337K – 1362
2017
Q1 		$337K Sell
8,607
-1,924
-18% -$61.3K ﹤0.01% 1156
2016
Q4 		$236K Buy
10,531
+310
+3% +$6.06K ﹤0.01% 1208
2016
Q3 		$232K Sell
10,221
-173,149
-94% -$4.06M ﹤0.01% 1224
2016
Q2 		$4.33M Sell
183,370
-83
-0% -$2.05K 0.01% 688
2016
Q1 		$3.74M Buy
183,453
+129
+0.1% +$4.09K 0.01% 759
2015
Q4 		$9.43M Sell
183,324
-40,965
-18% -$1.99M 0.02% 473
2015
Q3 		$9.56M Buy
224,289
+24,089
+12% +$1.16M 0.02% 461
2015
Q2 		$9.12M Buy
200,200
+600
+0.3% +$24.1K 0.02% 515
2015
Q1 		$7.58M Hold
199,600
– – 0.02% 624
2014
Q4 		$5.65M Hold
199,600
– – 0.01% 732
2014
Q3 		$5.05M Hold
199,600
– – 0.01% 768
2014
Q2 		$5.82M Sell
199,600
-800
-0.4% -$19.4K 0.01% 720
2014
Q1 		$5.19M Buy
200,400
+400
+0.2% +$10.7K 0.01% 740
2013
Q4 		$5.15M Hold
200,000
– – 0.01% 737
2013
Q3 		$5.35M Hold
200,000
– – 0.01% 681
2013
Q2 		$4.91M Buy
+200,000
New +$3.98M 0.01% 691

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments's PTLA Position: Q3 2018 in Review

Putnam Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2018, closing a stake of 28,456 shares — an estimated $1.07M sold.

Putnam Investments first reported a position in PTLA in Q2 2013 and held it in 20 quarters. The position peaked at $9.56M in Q3 2015. 197 funds tracked by Wall St. Rank hold PTLA as of Q3 2018.

  • Putnam Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Putnam Investments sold 28,456 Portola Pharmaceuticals, Inc. shares in Q3 2018, an estimated $1.07M.
  • Putnam Investments first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Putnam Investments's Portola Pharmaceuticals, Inc. position peaked at $9.56M in Q3 2015.
  • 197 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2018.

Based on Putnam Investments's 13F filing for Q3 2018, filed 14 Nov 2018.